Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1408 of 6351
-
Can a new Five-Category system predict which pulmonary embolism patients will crash?
Knowledge-focused Recruiting nowBackground: The 2026 American Heart Association/American College of Cardiology (AHA/ACC) Pulmonary Embolism Guideline (Creager et al., Circulation 2026) introduced a novel five-category (A-E) clinical classification system with subcategories and an R modifier, replacing prior ris…
Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Could vitamin B3 help beat TB? new trial launches
Disease control PausedThe purpose of this study is to determine if nicotinamide in combination with bedaquiline, pretomanid, and linezolid, is safe and effective in treating drug-susceptible pulmonary tuberculosis.
Phase 2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Probiotic cocktail may shield Antibiotic-Exposed infants from allergies
Prevention Not yet recruitingEarly antibiotic exposure is an important environmental factor that disrupts the establishment of the infant gut microbiota and leads to microbial dysbiosis. Accumulating epidemiological evidence indicates that exposure to antibiotics early in life (including both prenatal and po…
Sponsor: Peking University Third Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New CML drug asciminib under Real-World study
Disease control Recruiting nowThe aim of this study is to assess the real-world effectiveness of asciminib in Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) patients who were either newly diagnosed or previously treated with one ATP-competitive tyrosine kinase inhibito…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Custom-Made cancer vaccine enters early human testing
Vaccine Not yet recruitingThe purpose of this study is to evaluate the safety and tolerability of ABO2109 in combination with toripalimab, and to evaluate the immunogenicity, pharmacokinetics, pharmacodynamics, as well as biomarker characteristics of the investigational cancer vaccine. In addition, the an…
Early phase 1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC
-
New blood test could spot hidden belly infections faster
Diagnosis Recruiting nowThe NATURAL Study is a prospective, observational, pragmatic study of RNA biomarkers of infections to aid in the diagnosis of abdominal pain. Summary of Research Study: Hypothesis: A genomic-derived panel of 6 RNA biomarkers present in stabilized whole blood will provide diagno…
Sponsor: True Bearing Diagnostics, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Genetic clues to mysterious childhood movement disorders in vietnam
Knowledge-focused Recruiting nowThis observational patient registry aims to describe the clinical phenotypes and genetic findings of Vietnamese children with movement disorders of unknown etiology. Eligible participants are children with clinically confirmed movement disorders after evaluation by pediatric neur…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Can big data unlock better GERD treatment for chinese patients?
Knowledge-focused Recruiting nowThis retrospective, observational cohort study aimed to establish a comprehensive research cohort utilizing a large-scale prospective clinical registry. The primary objectives were to characterize the real-world demographic profiles, clinical features, psychological characteristi…
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
New balloon could improve treatment for blocked leg arteries
Disease control Recruiting nowThe primary objective of the study is to evaluate the long-term safety and effectiveness of the Advance Evero™ 18 Everolimus-coated Percutaneous Transluminal Angioplasty Balloon Catheter (hereafter referred to as the Evero drug-coated balloon \[DCB\]) in the treatment of the femo…
Sponsor: Cook Research Incorporated • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
New device aims to reduce heart transplant complications
Disease control Recruiting nowThe goal of this clinical trial is to test the feasibility of the study protocol comparing a novel temperature control system - Xo Port Organ Preservation System - to static ice for heat preservation for Heart Transplant. The main questions of the study are as follows: Does the …
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a tiny neck implant help repair MS-damaged nerves?
Disease control Recruiting nowThe MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device) in adult patients diagnosed with relapsing-remitting multiple sclerosis (RRMS). The SetPoint System is intended for adjunctive use with standard of care thera…
Sponsor: SetPoint Medical Corporation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New weekly shot could transform diabetes care
Disease control Recruiting nowThis study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when compared to placebo or semaglutide. The purpose of this clinical study is to find out if NNC0662-0419 is effective and safe for treating people …
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a simple CT scan save heart bypass patients from future attacks?
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate whether a coronary computed tomography angiography (CTCA)-guided strategy can reduce the risk of death, heart attack, stroke, and hospital admissions in patients experiencing angina or myocardial infarction following coronary artery …
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
New Low-Cost HPV test could save lives in poor countries
Diagnosis Recruiting nowIn high-income countries, prevention strategies have led to declines in cervical cancer rates by more than 75% in high-income countries. In contrast, low- and middle-income countries (LMICs) carry the global burden of cervical cancer with about 85% of new cases and 90% mortality.…
Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Could this pill prevent Chemo-Related bleeding risks?
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug trial hopes to thicken skin Disease's fate
Disease control Recruiting nowA Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Phase 2 • Sponsor: Mediar Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can exercise programs sharpen Kids' bodies and brains?
Knowledge-focused CompletedThis study aims to compare the effects of Progressive Functional Training and Dual-Task Training on motor skills in school-going children. It focuses on improving balance, coordination, strength, and motor-cognitive integration. A randomized clinical trial will be conducted on ch…
Sponsor: Riphah International University • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New hope for Crohn's? Real-World study tests IL-23 drugs
Disease control Recruiting nowThe goal of this observational study is to learn about the effectiveness and safety of IL-23 inhibitors in adults with active Crohn's disease in real-world clinical practice. The main questions it aims to answer are: * What proportion of participants achieve clinical remission a…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
App aims to unlock words after stroke
Symptom relief Recruiting nowThis study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language train…
Sponsor: Nunaps Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New study tracks how a drug combo affects liver function in advanced cancer patients
Knowledge-focused Recruiting nowItalian multicenter observational study to evaluate time to clinical hepatic decompensation, quality of life, effectiveness, and safety of tremelimumab plus durvalumab in patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic treatment…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC